Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Using RNAi in the clinic.

Kumlesh K Dev1

  • 1Novartis Institutes for BioMedical Research, Neuroscience Research, Novartis Pharma AG, WSJ 386-7-43, CH-4002 Basel, Switzerland. kumlesh_k.dev@novartis.com

Idrugs : the Investigational Drugs Journal
|April 6, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacokinetic Study of Fingolimod Nasal Films Administered via Nose-to-Brain Route in C57BL/6 J Mice as Potential Treatment for Multiple Sclerosis.

Pharmaceutical research·2024
Same author

The Effect of Donepezil Hydrochloride in the Twitcher Mouse Model of Krabbe Disease.

Molecular neurobiology·2024
Same author

The Effects of the S1P Receptor Agonist Fingolimod (FTY720) on Central and Peripheral Myelin in Twitcher Mice.

Biomedicines·2024
Same author

The Effects of Antipsychotics in Experimental Models of Krabbe Disease.

Biomedicines·2023
Same author

Investigating the Effects of Olaparib on the Susceptibility of Glioblastoma Multiforme Tumour Cells to Natural Killer Cell-Mediated Responses.

Pharmaceutics·2023
Same author

Fingolimod Rescues Memory and Improves Pathological Hallmarks in the 3xTg-AD Model of Alzheimer's Disease.

Molecular neurobiology·2022

RNA interference (RNAi) is a powerful gene silencing process. Small interfering RNA (siRNA) therapeutics show promise for treating diseases by blocking gene function in vivo.

Area of Science:

  • Molecular Biology
  • Genetics
  • Biotechnology

Background:

  • RNA interference (RNAi) is a natural gene silencing mechanism in living cells.
  • Targeting RNAi offers a novel therapeutic strategy for various diseases.
  • Advancements in predictive modeling simplify the design of siRNA-selective compounds.

Purpose of the Study:

  • To highlight recent progress in RNA interference (RNAi) research.
  • To discuss the potential of small interfering RNA (siRNA) as a human therapeutic.
  • To outline the goals of pharmaceutical and biotechnology industries in advancing siRNA compounds.

Main Methods:

  • Review of recent advances in siRNA research.
  • Analysis of predictive modeling in siRNA compound design.

Related Experiment Videos

  • Discussion of in vivo studies demonstrating siRNA efficacy.

    • Main Results:

    • Small interfering RNA (siRNA) effectively blocks gene function in vivo.
    • Predictive modeling has streamlined the development of siRNA-selective compounds.
    • RNAi represents a promising therapeutic approach for human diseases.

    Conclusions:

    • RNA interference (RNAi) is a potent new tactic in disease treatment.
    • siRNA therapeutics have significant potential for clinical application.
    • The pharmaceutical and biotechnology sectors are actively pursuing siRNA development.